Black Diamond Therapeutics | SCHEDULE 13G/A: Others
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Velleca Mark A.
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yurasov Sergey
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Buck Elizabeth
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jones Erika
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hatzis-Schoch Brent
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Campbell Shannon
Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(19.0%)
Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vestal Point Capital, LP(8.9%),Ryan Wilder(8.9%)
Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)
Black Diamond Therapeutics | 10-Q: Q3 2024 Earnings Report
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Campbell Shannon
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash
Unlock the Full List